Zhang Yafeng, Ma Yong, Jiang Jianwei, Ding Tao, Wang Jianwei
Department of Orthopaedics, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, No. 33 Houxixi Road, Wuxi, Jiangsu, China.
J Back Musculoskelet Rehabil. 2013;26(3):317-22. doi: 10.3233/BMR-130386.
Oxygen-ozone therapy is a minimally invasive treatment for lumbar disk herniation that exploits the biochemical properties of a gas mixture of oxygen and ozone. The purpose of our study was to prospectively evaluate the clinical effectiveness of oxygen-ozone therapy and compared the therapeutic outcome of injection of oxygen-ozone combined steroid with injection of ozone alone at different follow-up period.
From Aug 2005 to Mar 2009, 172 consecutive adult patients (92 men, 80 women; age range: 23-59 years) with low back pain and radicular pain were included in this study and were randomly assigned to two groups. 90 patients (group A) underwent intradiscal and intraforaminal injection of oxygen-ozone and 82 patients (group B) received the same treatment with additional injection of 1ml of compound betamethasone. Visual analogue scale (VAS) and the Japanese Orthopedic Association's evaluation system for lower back pain syndrome (JOA score) were administered before treatment and at 3 weeks, 6 and 12-month follow-up period to evaluate the clinical results.
Satisfactory clinical outcomes were obtained in both groups. The reduction of VAS score from baseline to the end of the study was 7.68 to 2.17 and 7.49 to 2.23 in group A and group B respectively, and there were remarkable improvements of mean JOA score and recovery rate in every follow-up time in both groups. Furthermore, in 3 weeks follow-up the JOA recovery rate of group B is higher than that of group A, which there was significant different, but there were no significant differences between two groups in 6 and 12 months.
In our study, oxygen-ozone nucleolysis provides excellent pain relief in most herniated disc patients who failed to respond to conservative therapy. And there was no significant statistical difference between treatment of injection of oxygen-ozone combined with steroid and ozone only in the 6 and 12 months follow-up. Therefore, O2-O3 seems to play a role in pain relief, and we suggest the administration of the O2-O3 mixture as a first-choice treatment before recourse to surgery or when surgery is not possible and the addition of epidural steroid infiltration is not required.
Level 1-1 (prospective study).
氧-臭氧疗法是一种用于腰椎间盘突出症的微创治疗方法,它利用了氧气和臭氧混合气体的生化特性。本研究的目的是前瞻性评估氧-臭氧疗法的临床疗效,并比较在不同随访期内,氧-臭氧联合类固醇注射与单纯臭氧注射的治疗效果。
2005年8月至2009年3月,本研究纳入了172例连续性成年患者(男92例,女80例;年龄范围:23 - 59岁),这些患者均有腰痛和神经根性疼痛,并被随机分为两组。90例患者(A组)接受椎间盘内和椎间孔内氧-臭氧注射,82例患者(B组)接受相同治疗并额外注射1ml复方倍他米松。在治疗前以及治疗后3周、6个月和12个月的随访期,采用视觉模拟评分法(VAS)和日本骨科学会下腰痛综合征评估系统(JOA评分)来评估临床疗效。
两组均取得了满意的临床效果。A组和B组从基线到研究结束时VAS评分的降低分别为7.68至2.17和7.49至2.23,两组在每次随访时JOA平均评分和恢复率均有显著改善。此外,在3周随访时,B组的JOA恢复率高于A组,差异有统计学意义,但在6个月和12个月时两组之间无显著差异。
在我们的研究中,氧-臭氧髓核溶解术能为大多数对保守治疗无效的椎间盘突出症患者提供出色的疼痛缓解效果。在6个月和12个月的随访中,氧-臭氧联合类固醇注射与单纯臭氧注射治疗之间无显著统计学差异。因此,O2 - O3似乎在缓解疼痛方面发挥作用,我们建议在诉诸手术之前或无法进行手术且不需要硬膜外类固醇浸润时,将O2 - O3混合气体作为首选治疗方法。
1 - 1级(前瞻性研究)。